Document is current
Any future updates will be listed below
-
Authors
Kork, Felix https://orcid.org/0000-0002-4703-2478
Liang, Yafen https://orcid.org/0000-0001-7902-7836
Ginde, Adit A.
Yuan, Xiaoyi https://orcid.org/0000-0002-2898-6495
Rossaint, Rolf
Liu, Hongfang https://orcid.org/0000-0003-2570-3741
Evers, Alex S.
Eltzschig, Holger K. https://orcid.org/0000-0002-5676-6473
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 13 March 2025
First Online: 9 April 2025
Competing interests
: Drs. Holger Eltzschig, Xiaoyi Yuan, and Yafen Liang received research funding through a contract between Akebia Therapeutics and UTHealth to support a clinical trial on the effect of vadadustat in hospitalized COVID-19 patients (NCT04478071). Akebia Therapeutics is not involved in conceptualization, design, data collection, analysis, the decision to publish, or the preparation of the manuscript. The remaining authors declare no competing interests.
